Guillain-Barré syndrome (GBS) is recognized as a complication that occurs after Campylobacter infection. Certain Penner serotypes, such as HS:19, are linked particularly to GBS in some parts of the world, and there is good evidence for restricted genetic diversity in these isolates. However, GBS also occurs after Campylobacter infection due to other serotypes. Therefore, we asked whether Campylobacter jejuni non-HS:19 serotypes associated with GBS have a clonal structure and differ from strains isolated from patients with Campylobacter gastroenteritis. A worldwide selected population of C. jejuni non-HS:19 strains associated with GBS and gastroenteritis was analyzed by use of multilocus enzyme electrophoresis, automated ribotyping, pulsed-field gel electrophoresis, and flagellin gene typing. The results show that these isolates represent a heterogenic population and do not constitute a unique population across serotypes. No epidemiologic marker for GBS-associated strains was identified.
tissue. This molecular mimicry in C. jejuni is hypothesized to elicit a humoral response in susceptible hosts that results in antibody-mediated nerve damage either to the Schwann cell surface or to the axolemma [3] .
Campylobacter strains with certain Penner heat-stabile (HS) serotypes, including HS:19 and HS:41, have been reported to be overrepresented among isolates from GBS cases, compared with enteritis cases in Japan, South Africa, China, and Mexico. Several studies indicate that HS:19 and HS:41 have a clonal population structure [4] [5] [6] and suggest that these serotypes might have unique virulence properties that are linked to the relationship between infection and GBS. However, data from the United Kingdom and, more recently, from The Netherlands suggest that this phenomenon may not be the case in all geographic areas of the world, since other more common serotypes have been isolated from patients with GBS [7] . The serotypes presently associated with GBS in the literature include HS:1, HS:2, HS:4, HS:4/50, HS:5, HS:10, HS:13/65, HS:16, HS:19, HS:23, HS:35, HS:37, HS:41, HS:44, and HS:64 [1, 7] .
Recent studies have shown that the thermostable serotype determinant for the Penner serotyping scheme is capsular polysaccharides, rather than lipooligosaccharides. These structural differences in the putative virulence determinant for GBS and the component for the serotyping scheme prompted us to look for similarities between non-HS:19 strains that trigger GBS and those that do not. Here, we present an analysis of strains from different worldwide geographic locations involved in GBS and an analysis of control strains not related to GBS, to determine a possible serotype-independent epidemiologic marker in GBS strains.
Materials and Methods
Bacterial strains. We analyzed 11 non-HS:19 GBS-related C. jejuni strains isolated from patients in 6 geographically distinct locations (China, Denmark, Mexico, Thailand, United Arab Emirates, and United States) and 47 control strains. Twelve HS:19 strains also were included for comparative purposes (table 1) . The species identity of strains was checked, as described elsewhere [6] .
Diagnostic criteria. Most patients with GBS were classified according to clinical criteria, in which case we refer to the diagnosis as GBS. These are more likely represented by acute inflammatory demyelinating polyneuropathy type pathology. Isolates from patients in Northern China were further classified as acute motor axonal neuropathy (AMAN), one of the pathologic forms of GBS, on the basis of electrophysiologic characteristics [8] .
Phenotypic analysis. Strains were serotyped by use of the Penner serotyping system, as described elsewhere [9] , except that the complete set of C. jejuni antisera was used. The presence of the GM1-like epitope was detected by cholera toxin binding, as described elsewhere [10] .
Molecular analysis.
Multilocus enzyme electrophoresis (MLEE) was done, as described elsewhere [6] . HaeIII RiboPrinting (automated ribotyping using the RiboPrinter; Qualicon) was done, as described elsewhere [11] . Pulsed-field gel electrophoresis (PFGE) was done with each of 3 restriction enzymes (SmaI, SalI, and KpnI; authors' unpublished method, available on request from J.E.). Restriction fragment length polymorphism (RFLP) analysis of the C. jejuni flaA gene (fla typing) was done, as described elsewhere [12] .
Data analysis. For analysis of MLEE data, genetic diversity, allele frequencies, and genetic distances were calculated, as described elsewhere [6] . Automated ribotyping and PFGE profiles were grouped together on the basis of visual analysis with the aid of a software program (BioNumerics, version 2.0; Applied Maths), using the Dice coefficient and unweighted pair group method with averages (UPGMA) clustering. Any discernible difference (i.e., change of band positions and/or ‫ע‬у1 bands) between patterns was considered to be significant, when assessing interstrain relationships. Profiles were added to an existing database with automated ribotyping and PFGE data. The fla types were determined by analysis of RFLPs with ProRFLP (DNA ProScan) and by comparison with a known database of fla types, which currently consists of 120 fla types [12] .
Concordance between typing results of different techniques for the non-HS:19 group of strains was analyzed by use of a software program (BioNumerics). Assigned types were entered into the program as numerical values and were compared by means of the categorical coefficient. Congruence was calculated by use of Pearson's product-moment coefficient.
Results
Overall, there was significant diversity among all the isolates, regardless of the method used to determine diversity ( figure 1 ). Apart from INP16, they also shared the same fla type (type 9). Last, an American HS: 4 GBS-related strain (JHU2) had the same pattern as the HS: 10 serostrain. Of all 58 strains, 33 (57%) could be referred to 15 groups of identical strains.
PFGE. The discriminatory potential of the 3 enzymes used for PFGE typing differed from each other. The 58 C. jejuni strains were divided into 39, 28, and 47 PFGE types by means of SmaI, SalI, and KpnI, respectively (table 1). The 11 non-HS:19 GBS-related strains were assigned to 10, 8, and 11 different profiles, respectively, by use of SmaI, SalI, and KpnI. Dendograms of PFGE results (not presented) showed that the GBS-related strains were spread throughout the dendrogram, regardless of the enzyme used.
flaA polymerase chain reaction-RFLP. A total of 26 different fla types were identified among the analyzed 54 strains (table 1). Ten groups of identical strains, each consisting of 2-9 strains, were found. Seven of the GBS-related strains were part of these groups.
Typing system concordance. In this study, there were different levels of agreement for grouping the non-HS:19 strains and, in general, variable typing system concordance. The highest level of concordance (89.8%) was found between the 2 methods with the highest number of types, MLEE and Kpnl PFGE (49 and 47 types, respectively), whereas the lowest level of concordance (39.0%) was registered between SalI PFGE and flaA typing, which had the lowest number of types (29 and 27 types, respectively). For PFGE, a number of strains could be identified as genetically identical by 2 enzymes, but complete agreement among all 3 enzymes was seen for only 8 controls of serotypes HS:1,44; HS:6,7; HS:19; and HS:41.
GM1-like epitope expression. No significant difference for the presence of the GM1-like epitope was observed among GBSassociated and non-GBS-associated strains. For GBS-related Figure 1 . RiboGroup patterns of 70 tested strains ordered according to their similarity, using unweighted pair group method with averages clustering. Dice similarity was used. Serotypes and RiboGroups are presented, with the no. of strains shown in parentheses. Guillain-Barré syndrome-related strains are underlined. Banding patterns for each RiboGroup are shown. Scale refers to percentage of similarity. non-HS:19 strains, 4 (36%) of 11 were positive for the epitope, compared with 12 (27%) of 44 control strains (table 1) .
Discussion
In general, all methods of analysis showed a high diversity in the studied population of strains; however, group definition of strains varied considerably between methods. Collectively, the 11 GBS-related strains of different serotypes did not represent separate genetic lineages distinct from enteritis-associated strains and strains from animals.
A specific epidemiologic marker (i.e., a specific band[s] or protein allelic profile) that associated only with GBS strains could not be identified. At present, the lack of such a molecular marker hampers the possibilities of intervention, infection control, and risk-assessment studies of Campylobacter infections with strains capable of triggering GBS in susceptible hosts. We applied a number of different typing methods to examine a number of different parts of the bacterial genome. We previously have found that these methods are useful for differentiating among C. jejuni strains from different sources [11, 15] , but we cannot dismiss the possibility that another typing or characterization system could identify neuropathic C. jejuni strains, although they are not clonal in nature.
In our study, none of the more discriminatory methods showed a perfect hierarchical structure with serotyping as the primary system. This is in agreement with our previous observations [11] . However, there was a clear tendency for the MLEE and automated ribotyping methods to split serotypes HS:5, HS: 37, HS:19, and, to a lesser extent, HS:2 into closely related or similar types (clonal groups). However, for each serotype, у1 strains could be identified outside these groups.
MLEE has been used to assess genetic diversity among a variety of bacterial pathogens and has been important in identifying pathogenic clones with unique virulence properties [16] . The non-HS:19 strains representing a collection from worldwide sources showed significant genetic diversity, which is in contrast to our analysis of HS:19 strains [6] , of which most belonged to a single major clone, ET4. Furthermore, HS:41 strains (2 associated with GBS and 5 with enteritis) fell into 3 distinct clusters, of which the 2 GBS strains were more closely related to HS:19 strains than were the non-GBS strains. These data suggest that HS:19 may be a direct descendant of HS:41 and may also suggest that these 2 serotypes share common virulence factors (if there are any) associated with GBS. Although the number of isolates studied was small, these data also suggest that there may be more diversity among HS:41 isolates than suggested in recent studies of this particular serotype [4] . HS:41 isolates have been strongly associated with GBS in South Africa but have not been reported from patients with GBS in other countries.
Our results support the recently published findings of substantial heterogeneity of C. jejuni strains associated with GBS or the variant pattern, Miller Fisher syndrome (MFS), in a restricted geographic area of the world [7] . In this analysis of strains from 17 Dutch patients and 1 Belgian patient, no clustering of GBS-or MFS-related strains were found by serotyping, flaA-RFLP, amplified fragment length polymorphism analysis, PFGE, or random amplified polymorphic DNA analysis. In addition, our findings are consistent with the results of 2 HS:19 flaA-RFLP studies that included a modest number of non-HS:19 strains [5, 17] .
One isolate, HB96-35, from a patient with AMAN in Northern China was found to be serotype HS:53. We believe this to be the first report of the identification of serotype HS: 53 being associated with GBS. All the typing methods identified this strain as unique and not related to any other strain included in this study.
The finding of extensive genetic diversity in non-HS:19 strains does not preclude the hypothesis of common virulence factors in GBS-related strains, especially since small numbers of GBS isolates are available for analysis and since it takes some time to establish large collections. Thus, characterization of additional isolates from patients with GBS, both of the HS: 19 and non-HS:19 serotypes, should be performed. With the completion of the Campylobacter genome sequence and other studies on the molecular basis of ganglioside mimicry in C. jejuni, studies on the molecular pathogenesis of Campylobacter should help to solve the mystery of this intriguing association with GBS.
